Eddie Sullivan, SAB Biotherapeutics president and CEO
South Dakota-based Covid-19 transgenic cow antibody startup claims its first PhIII win
SAB Biotherapeutics, known for collecting and distilling antibodies from cows with humanized immune systems, on Wednesday said a Phase III trial it ran for its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.